Abstract

The fungus Aspergillus fumigatus is a leading infectious killer in immunocompromised patients. Calcineurin, a calmodulin (CaM)-dependent protein phosphatase comprised of calcineurin A (CnaA) and calcineurin B (CnaB) subunits, localizes at the hyphal tips and septa to direct A. fumigatus invasion and virulence. Here we identified a novel serine-proline rich region (SPRR) located between two conserved CnaA domains, the CnaB-binding helix and the CaM-binding domain, that is evolutionarily conserved and unique to filamentous fungi and also completely absent in human calcineurin. Phosphopeptide enrichment and tandem mass spectrometry revealed the phosphorylation of A. fumigatus CnaA in vivo at four clustered serine residues (S406, S408, S410 and S413) in the SPRR. Mutation of the SPRR serine residues to block phosphorylation led to significant hyphal growth and virulence defects, indicating the requirement of calcineurin phosphorylation at the SPRR for its activity and function. Complementation analyses of the A. fumigatus ΔcnaA strain with cnaA homologs from the pathogenic basidiomycete Cryptococcus neoformans, the pathogenic zygomycete Mucor circinelloides, the closely related filamentous fungi Neurospora crassa, and the plant pathogen Magnaporthe grisea, revealed filamentous fungal-specific phosphorylation of CnaA in the SPRR and SPRR homology-dependent restoration of hyphal growth. Surprisingly, circular dichroism studies revealed that, despite proximity to the CaM-binding domain of CnaA, phosphorylation of the SPRR does not alter protein folding following CaM binding. Furthermore, mutational analyses in the catalytic domain, CnaB-binding helix, and the CaM-binding domains revealed that while the conserved PxIxIT substrate binding motif in CnaA is indispensable for septal localization, CaM is required for its function at the hyphal septum but not for septal localization. We defined an evolutionarily conserved novel mode of calcineurin regulation by phosphorylation in filamentous fungi in a region absent in humans. These findings suggest the possibility of harnessing this unique SPRR for innovative antifungal drug design to combat invasive aspergillosis.

Highlights

  • Invasive fungal infections are a leading cause of death in immunocompromised patients [1]

  • Currently available calcineurin inhibitors FK506 and cyclosporine A are active in vitro against A. fumigatus [5], they are immunosuppressive in the host, limiting therapeutic effectiveness

  • We defined an evolutionarily conserved novel mode of calcineurin regulation by phosphorylation in filamentous fungi that is responsible for virulence in the opportunistic human pathogen, Aspergillus fumigatus

Read more

Summary

Introduction

Invasive fungal infections are a leading cause of death in immunocompromised patients [1]. With a 40–60% mortality rate, invasive aspergillosis, caused by the filamentous fungus Aspergillus fumigatus, is the most frequent fungal cause of mortality [2]. Through both genetic and pharmacologic inhibition, we have established that the conserved phosphatase calcineurin is necessary for invasive fungal disease [3,4]. Currently available calcineurin inhibitors FK506 and cyclosporine A are active in vitro against A. fumigatus [5], they are immunosuppressive in the host, limiting therapeutic effectiveness. Calcineurin is a Ca2+/calmodulin (CaM)-dependent protein phosphatase comprised of a catalytic A and regulatory B subunit heterodimeric complex [6]. Calcineurin is activated after Ca2+/ CaM binds to calcineurin A at the CaM-binding domain (CaMBD), adjacent to the calcineurin B binding helix (CnBBH) in its regulatory domain and displaces the auto-inhibitory domain (AID) [6,7]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call